NCT02307084

Brief Summary

The long saphenous vein is traditionally harvested for use as a conduit in coronary artery bypass grafting surgery. Currently, the long saphenous vein is not imaged prior to surgery. This study aims to evaluate preoperative ultrasound mapping of the long saphenous vein to to improve patient and clinical outcomes.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 1, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 3, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

February 1, 2015

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 13, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 13, 2017

Completed
Last Updated

May 3, 2019

Status Verified

May 1, 2019

Enrollment Period

2 years

First QC Date

December 1, 2014

Last Update Submit

May 1, 2019

Conditions

Keywords

surgical site infectionlong saphenous veincoronary artery bypass grafting

Outcome Measures

Primary Outcomes (1)

  • Surgical site infection at the conduit harvest site

    The ASEPSIS tool is a well established tool to quantify wound healing disturbances.

    30 days of CABG surgery

Secondary Outcomes (5)

  • Ability to identify abnormal segments of vein on ultrasound and direct surgical excision away from such areas.

    baseline

  • Time taken to harvest a suitable conduit.

    intraoperative

  • Length of lower limb vein harvest wounds.

    1 day Post-operation

  • Blood loss from the vein harvest wound

    intraoperative

  • Patient questionnaire to assess wound/scar satisfaction and complications.

    30 days from surgery

Study Arms (2)

Pre-operative ultrasound imaging

EXPERIMENTAL

Subjects that are randomly allocated to this group will have ultrasound imaging assessment of the long saphenous vein in both legs. This will allow assessment of the suitability of the long saphenous vein and marking of the distribution prior to heart bypass surgery to allow targeted harvesting of a bypass conduit.

Procedure: Ultrasound imaging of the long saphenous vein

Current protocol

NO INTERVENTION

This group will not undergo pre-operative ultrasound imaging of the long saphenous vein in accordance with current Trust protocols.

Interventions

Ultrasound imaging of the long saphenous vein from the ankle to the saphenofemoral junction. This will allow assessment of vein calibre, branches and bifurcations, presence of thrombophlebitis and distribution. The presence of a proximal deep vein thrombosis will also be assessed.

Pre-operative ultrasound imaging

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Listed for CABG surgery with long saphenous vein harvesting.
  • Aged over 18 years.
  • Capable of providing informed consent.
  • Five days or more to consider participation prior to surgery if an outpatient or 2 days if an inpatient referred by their consultant.
  • Operative procedure to be undertaken at the Bristol Heart Institute.

You may not qualify if:

  • Operation within 48h hours if an inpatient or 5 days if an outpatient.
  • Aged below 18 years of age.
  • Incapable of providing informed consent i.e. confirmed diagnosis of dementia or other mental health conditions or unconscious.
  • Current participant in a different randomised control trial.
  • Pregnancy
  • Active cancer
  • Immunosuppressed.
  • Non-English speaker that requires a Trust translator.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Bristol NHS FT

Bristol, BS2 8HW, United Kingdom

Location

MeSH Terms

Conditions

Surgical Wound Infection

Condition Hierarchy (Ancestors)

Wound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Reshat Reshat, PhD

    University Hospital Bristol NHS FT

    PRINCIPAL INVESTIGATOR
  • Teresa Robinson, MSc

    University Hospital Bristol NHS FT

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 1, 2014

First Posted

December 3, 2014

Study Start

February 1, 2015

Primary Completion

February 13, 2017

Study Completion

February 13, 2017

Last Updated

May 3, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations